This is a preview of subscription content, log in via an institution to check access.
References
Bieck PR, Antonin KH (1987) Oral tyramine pressor test and the safety of MAO inhibitor drugs. J Clin Psychopharm (in press)
Bieck PR, Antonin KH, Cremer G, Gleiter Ch (1984) Tyramine pressor effects of CGP 11 305 A in comparison to tranylcypromine after prolonged treatment of human volunteers. In: Monoamine Oxidase and Disease. Academic Press, London, pp 505–513
Korn A, Eichler HG, Fischbach R, Gasic S (1986) Moclobemide, a new reversible MAO inhibitor — interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients. Psychopharmacology 88:153–157
Ross EM, Gilman G (1985) Pharmacodynamics: Mechanism of drug action and the relationship between drug concentration and effect. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics, 7th edn. Macmillan, New York, pp 35–48
Simpson GM, White K (1984) Tyramine studies and the safety of MAOI Drugs. J Clin Psychiatry 45:59–61
References
Korn A, Eichler HG, Fischbach R, Gasic S (1986a) Moclobemide, a new reversible MAO inhibitor — interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients. Psychopharmacology 88:153–157
Korn A, Da Prada M, Raffesberg W, Gasic S, Eichler HG (1986b) Effect of a new reversible MAO-inhibitor moclobemide on the tyramine absorption and pressure sensitivity. Acta Pharmacol Toxicol 59:(Suppl V) Abstract No 749
Simpson GM, White K (1984) Tyramine studies and the safety of MAOI drugs. J Clin Psychiatry 45:59–61
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schulz, R., Bieck, P.R. & Korn, A. Oral tyramine pressor test and the safety of MAO inhibitor drugs. Psychopharmacology 91, 515–516 (1987). https://doi.org/10.1007/BF00216021
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00216021